Cg Oncology Inc’s recently made public that its Director LEONARD E POST acquired Company’s shares for reported $0.11 million on Mar 17 ’25. In the deal valued at $27.80 per share,4,000 shares were bought.
Then, POST LEONARD E sold 1,000 shares, generating $28,610 in total proceeds. Upon selling the shares at $28.61, the Director now owns 0 shares.
Before that, POST LEONARD E sold 1,000 shares. Cg Oncology Inc shares valued at $29,660 were divested by the Director at a price of $29.66 per share. As a result of the transaction, POST LEONARD E now holds 0 shares, worth roughly $0.0.
TD Cowen initiated its Cg Oncology Inc [CGON] rating to a Buy in a research note published recently. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. RBC Capital Mkts began covering CGON with “an Outperform” recommendation on September 23, 2024. ROTH MKM started covering the stock on August 28, 2024. It rated CGON as “a Buy”.
Price Performance Review of CGON
On Monday, Cg Oncology Inc [NASDAQ:CGON] saw its stock fall -0.47% to $27.67. Over the last five days, the stock has gained 5.65%. Cg Oncology Inc shares have fallen nearly -3.52% since the year began. Nevertheless, the stocks have fallen -30.46% over the past one year. While a 52-week high of $46.99 was reached on 01/07/25, a 52-week low of $23.91 was recorded on 03/04/25. SMA at 50 days reached $28.34, while 200 days put it at $32.94.
Levels Of Support And Resistance For CGON Stock
The 24-hour chart illustrates a support level at 27.14, which if violated will result in even more drops to 26.60. On the upside, there is a resistance level at 28.21. A further resistance level may holdings at 28.74. The Relative Strength Index (RSI) on the 14-day chart is 52.89, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.96, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 20.65%. Stochastics %K at 70.14% indicates the stock is a holding.
How much short interest is there in Cg Oncology Inc?
A steep rise in short interest was recorded in Cg Oncology Inc stocks on 2025-02-28, growing by 0.22 million shares to a total of 7.0 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 6.78 million shares. There was a rise of 3.1%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 28, 2024 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $65 price target.
